뒤로Practical Applications of Immunology: Vaccines and Diagnostic Immunology
스터디 가이드 - 스마트 노트
자료에 맞춘 맞춤형 노트, 핵심 정의, 예시, 맥락을 확장해 제공합니다.
Practical Applications of Immunology
Vaccines: Definition and Principles
Vaccines are a cornerstone of modern immunology and microbiology, providing protection against infectious diseases by stimulating the immune system. The term vaccine originates from the Latin word vacca (cow), reflecting Edward Jenner's use of cowpox to prevent smallpox.
Vaccine: A suspension of organisms or fractions of organisms that induce immunity.
Variolation: Early method of inoculating smallpox into the skin.
Vaccination: The process of administering vaccines to provoke an immune response.
Primary immune response: Initial activation of the immune system, leading to antibody and memory cell formation.
Secondary immune response: Rapid, intense response upon subsequent exposure to the same antigen.
Herd immunity: Immunity in most of the population, reducing outbreaks due to lack of susceptible individuals.
Types of Vaccines and Their Characteristics
Vaccines are classified based on their composition and method of action. Each type has specific advantages and limitations.
Live attenuated vaccines: Contain weakened pathogens; closely mimic natural infection and confer lifelong cellular and humoral immunity.
Inactivated (killed) vaccines: Contain killed pathogens; safer but require repeated booster doses and induce mostly humoral immunity.
Subunit vaccines: Use antigenic fragments to stimulate an immune response.
Recombinant vaccines: Subunit vaccines produced by genetic modification.
Toxoids: Inactivated toxins used to induce immunity against toxin-producing bacteria.
Virus-like particle (VLP) vaccines: Resemble intact viruses but lack viral genetic material.
Polysaccharide vaccines: Made from molecules in pathogen capsules; not very immunogenic.
Conjugated vaccines: Used for children with poor immune response to capsular polysaccharides.
Nucleic acid (DNA) vaccines: Injected naked DNA produces the protein antigen encoded in the DNA, stimulating humoral and cellular immunity.
Recombinant vector vaccines: Avirulent viruses or bacteria genetically modified to deliver genes coding for antigens.

Example:
The live attenuated measles vaccine provides robust, long-lasting immunity, while the inactivated polio vaccine requires multiple doses.
CDC-Recommended Vaccines to Prevent Bacterial Diseases
The Centers for Disease Control and Prevention (CDC) recommends specific vaccines to prevent bacterial diseases. These recommendations are based on disease prevalence, risk groups, and booster requirements.
Disease | Vaccine | Recommendation | Booster |
|---|---|---|---|
Haemophilus influenzae type b meningitis | Polysaccharide from Haemophilus influenzae type b | Children 2–18 months | None recommended |
Meningococcal meningitis | Purified polysaccharide from Neisseria meningitidis | For people with substantial risk of infection; recommended for college freshmen, especially living in dormitories | Need not established |
Pneumococcal pneumonia | Purified polysaccharide from 13 or 23 strains of Streptococcus pneumoniae | Pv13 for adults with certain chronic diseases; people over 65; Pv13 for children 2–5 months | None if first dose administered 2–4 months |
Tetanus, diphtheria, and pertussis | Tdap (children younger than 7); Td booster for tetanus and pertussis | DTP children 2–18 months; 4–6 years; Tdap for 11–12 years; Td for children aged 11–12 years and adults | Tdap or Td every 10 years |

CDC-Recommended Vaccines to Prevent Viral Diseases
Vaccines are also recommended to prevent viral diseases, with specific guidelines for age, risk groups, and booster schedules.
Disease | Vaccine | Recommendation | Booster |
|---|---|---|---|
Chickenpox | Attenuated virus | For infants aged 12 months | Duration of immunity not known |
Hepatitis A | Inactivated virus | Children at age 1 year; for travel to endemic areas; homosexual men; street drug users; receive blood-clotting factors | Duration of protection estimated at about 10 years |
Hepatitis B | Antigenic fragments of virus | For infants and children; for adults, especially health workers, homosexual men, injecting street drug users, and household contacts of hepatitis B carriers | Duration of protection at least 7 years; need for boosters not established |
Herpes zoster | Attenuated virus | Adults over 60 years | None recommended |
Human papillomavirus | Antigenic fragments of virus | Boys and girls ages 11–12 | Duration at least 5 years |
Influenza | Injected vaccine; inactivated virus (A nasal administered attenuated vaccine is available for children; the inactivated vaccine is not available for the 2016–2017 flu season) | Everyone over 6 months of age | Annual |

Vaccine Production, Delivery Methods, and Formulations
Advances in vaccine technology have led to new production methods and delivery systems, improving accessibility and effectiveness.
Plant-based vaccines: Vaccines developed without animal hosts, using plants as sources.
Oral vaccines: More convenient and can enhance mucosal immunity.
Dry vaccines (skin patch): Nanopatch™ delivers a dry formulation to the skin, requiring no refrigeration and targeting high numbers of antigen-presenting cells (APCs).
Multiple-combination vaccines: Combine several antigens to protect against multiple diseases.
Adjuvants: Chemical additives (e.g., alums, monophosphoryl lipid A) added to vaccines to improve effectiveness by enhancing the innate immune response.
Example:
Nanopatch™ technology allows for vaccine delivery without refrigeration, making it suitable for remote areas.
Diagnostic Immunology: Principles and Techniques
Diagnostic immunology uses the specificity and sensitivity of antibody-antigen interactions to detect diseases.
Sensitivity: Probability that the test is reactive if the specimen is a true positive.
Specificity: Probability that a positive test will not be reactive if a specimen is a true negative.
Monoclonal antibodies (Mabs): Uniform, highly specific antibodies produced in large quantities by hybridomas; used in diagnostics and therapy.
Precipitation reactions: Soluble antigens react with antibodies to form lattices that precipitate from solution.
Agglutination reactions: Particulate antigens bind to antibodies, forming visible aggregates.
Hemagglutination: Agglutination of red blood cell surface antigens and complementary antibodies; used in blood typing.
Neutralization tests: Antigen-antibody reactions block harmful effects of exotoxins or viruses.
Complement-fixation tests: Detect small amounts of antibody by binding complement serum protein to the antigen-antibody complex.
Fluorescent-antibody techniques: Use fluorescent dyes combined with antibodies to identify microorganisms or detect specific antibodies.
ELISA (Enzyme-Linked Immunosorbent Assay): Direct ELISA detects antigens; indirect ELISA detects antibodies.
Western blotting: Identifies proteins via electrophoresis and immunoblotting.
Example:
Monoclonal antibodies are used in home pregnancy tests to detect the presence of human chorionic gonadotropin (hCG).
Big Picture: Vaccine-Preventable Diseases
Immunization campaigns have dramatically reduced the incidence of vaccine-preventable diseases. However, some diseases persist due to low vaccination rates, poverty, and lack of health infrastructure. Global initiatives aim to eliminate diseases such as measles, rubella, and polio.
Diphtheria: Over 15,000 deaths in 1921; only a single case reported since 2003 after vaccine introduction.
Measles and Rubella Initiative: Goal to eliminate measles deaths and congenital rubella syndrome.
Global Polio Eradication Initiative: Polio eliminated from most of the world, with ongoing efforts in a few countries.
Additional info:
Vaccines are the safest and most effective means of preventing infectious diseases in children. On rare occasions, vaccines can cause disease, but the risks are minimal compared to the benefits.